Stay updated on Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A banner was added announcing NIH website transition updates and saying that “Super Intelligence” may appear in place of “Artificial Intelligence” across NIH content.
    Difference
    1%
    Check dated 2026-10-26T11:56:59.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2, while the study record page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-19T12:51:57.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1; the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-12T14:28:24.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    The 403 Forbidden page was replaced with the actual ClinicalTrials.gov study details for NCT03410784. This change makes the study information accessible again.
    Difference
    0.5%
    Check dated 2026-09-28T17:37:46.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A 403 Forbidden error page is now shown at the study URL, replacing the expected study content with a generic error screen and the site header/footer. This reflects an access/server error rather than a substantive update to the page's information.
    Difference
    19%
    Check dated 2026-09-21T22:28:14.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page now includes 'Ovarian cancer' in the related topics and adds a MedlinePlus Genetics related topics entry. These changes broaden educational cross-links and navigation for readers without altering the study details.
    Difference
    0.1%
    Check dated 2026-09-14T18:46:05.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial page.